These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 15990333)
1. Plasmacytoid dendritic cells--virus experts of innate immunity. Barchet W; Cella M; Colonna M Semin Immunol; 2005 Aug; 17(4):253-61. PubMed ID: 15990333 [TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells in immunity. Colonna M; Trinchieri G; Liu YJ Nat Immunol; 2004 Dec; 5(12):1219-26. PubMed ID: 15549123 [TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses. Zhang Z; Wang FS Cell Mol Immunol; 2005 Dec; 2(6):411-7. PubMed ID: 16426490 [TBL] [Abstract][Full Text] [Related]
4. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464 [TBL] [Abstract][Full Text] [Related]
7. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Dumitriu IE; Baruah P; Bianchi ME; Manfredi AA; Rovere-Querini P Eur J Immunol; 2005 Jul; 35(7):2184-90. PubMed ID: 15915542 [TBL] [Abstract][Full Text] [Related]
8. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon. Jaehn PS; Zaenker KS; Schmitz J; Dzionek A Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320 [TBL] [Abstract][Full Text] [Related]
9. Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. Guiducci C; Coffman RL; Barrat FJ J Intern Med; 2009 Jan; 265(1):43-57. PubMed ID: 19093959 [TBL] [Abstract][Full Text] [Related]
10. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells. Löseke S; Grage-Griebenow E; Heine H; Wagner A; Akira S; Bauer S; Bufe A Scand J Immunol; 2006 Apr; 63(4):264-74. PubMed ID: 16623926 [TBL] [Abstract][Full Text] [Related]
11. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792 [TBL] [Abstract][Full Text] [Related]
12. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation? Haeryfar SM Trends Immunol; 2005 Jun; 26(6):311-7. PubMed ID: 15922947 [TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids. Conrad C; Meller S; Gilliet M Semin Immunol; 2009 Jun; 21(3):101-9. PubMed ID: 19250840 [TBL] [Abstract][Full Text] [Related]
17. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Soumelis V; Liu YJ Eur J Immunol; 2006 Sep; 36(9):2286-92. PubMed ID: 16892183 [TBL] [Abstract][Full Text] [Related]
18. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740 [TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. Decalf J; Fernandes S; Longman R; Ahloulay M; Audat F; Lefrerre F; Rice CM; Pol S; Albert ML J Exp Med; 2007 Oct; 204(10):2423-37. PubMed ID: 17893202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]